P. Milligan

发表

Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.

B. Gage, K. Woeltje, Tzu‐Fei Wang, 2014, Thrombosis research.

Effect of warfarin nonadherence on control of the International Normalized Ratio.

B. Gage, A. Waterman, G. Banet, 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Safe Prescribing: An Educational Intervention For Medical Students

C. McNaughton, J. Garbutt, P. Milligan, 2006, Teaching and learning in medicine.

Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.

B. Gage, A. Waterman, G. Banet, 2003, Chest.

Perioperative reduction of the warfarin dose.

B. Gage, G. Banet, P. Milligan, 2003, The American journal of medicine.

Establishing and running an effective telephone-based anticoagulation service.

B. Gage, A. Waterman, G. Banet, 2001, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin

Howard L McLeod, Paul E Milligan, B. Gage, 2003, Thrombosis and Haemostasis.

Anticoagulation: Optimal Initial Dose Adjustment of Warfarin in Orthopedic Patients

R. Barrack, B. Gage, C. Eby, 2007, The Annals of pharmacotherapy.

Risk factors for bleeding in patients taking coumarins.

B. Gage, R. Beyth, P. Milligan, 2002, Current hematology reports.

Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin‐sensitive

B. Gage, C. Eby, B. Gage, 2007, Journal of thrombosis and haemostasis : JTH.

Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system.

J. Krettek, W. C. Dunagan, C. Hoehner, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Reducing medication prescribing errors in a teaching hospital.

Jane Garbutt, Paul E Milligan, W Claiborne Dunagan, 2008, Joint Commission journal on quality and patient safety.

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

M. Rich, B. Gage, M. Radford, 2006, American heart journal.

Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients

B. Gage, Tzu‐Fei Wang, C. A. Wong, 2013, Thrombosis and Haemostasis.

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy

Jenine K. Harris, P. Ridker, R. Glynn, 2010, Journal of thrombosis and haemostasis : JTH.

Gamma-glutamyl carboxylase and its influence on warfarin dose

Elena Deych, Petra Lenzini, Paul M Ridker, 2010, Thrombosis and Haemostasis.

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

R L Berg, M Pirmohamed, P. Deloukas, 2010, Clinical pharmacology and therapeutics.

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

Deepak Voora, Elena Deych, Paul E Milligan, 2007, Blood.

A Practical Approach to Measure the Quality of Handwritten Medication Orders: A Tool for Improvement

Candace D. McNaughton, Jane Garbutt, Paul E. Milligan, 2005 .

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype

Howard L McLeod, Deepak Voora, Paul E Milligan, 2005, Thrombosis and Haemostasis.

Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients

R. Barrack, B. Gage, C. Eby, 2008, Journal of thrombosis and haemostasis : JTH.

Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes

B. Gage, B. Gage, G. Grice, 2008, Journal of thrombosis and haemostasis : JTH.

Substitution of Generic Warfarin for Coumadin in an HMO Setting

B. Gage, A. Waterman, G. Banet, 2002, The Annals of pharmacotherapy.

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

M. Rieder, P. Ridker, R. Glynn, 2008, Clinical pharmacology and therapeutics.

Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.

B. Gage, P. Milligan, 2005, Thrombosis research.

Genetic-based dosing in orthopaedic patients beginning warfarin therapy Running Title: Genetic-Based Warfarin Dose Refinement

R. Barrack, D. Voora, B. Gage, 2017 .

Patient and physician satisfaction with a telephone-based anticoagulation service

Paul E. Milligan, Brian F. Gage, B. Gage, 2001, Journal of General Internal Medicine.

Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes

S. Ceesay, G. Walraven, P. Milligan, 2001 .

The first experience of information pharmacogenetic testing to predict the dose of warfarin

M. Rieder, P. Ridker, R. Glynn, 2011 .

Optimal initial dose adjustment of warfarin in orthopedic patients.

J. Clohisy, P. Lenzini, G. Grice, 2007, The Annals of pharmacotherapy.

A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans

P. Ridker, D. Koboldt, D. Voora, 2010, Clinical pharmacology and therapeutics.

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

M. Rieder, P. Ridker, R. Glynn, 2008, Clinical pharmacology and therapeutics.

Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients

R. Barrack, B. Gage, C. Eby, 2008, Journal of thrombosis and haemostasis : JTH.

Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system.

Christine M. Hoehner, J. Krettek, P. Milligan, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Sustainability of a Real-Time Informatics Alert to Prevent Inpatient Severe Hypoglycemia

Kevin M. Heard, P. Milligan, Mary Clare Blackburn, 2018, Diabetes.